Canada · Venture startup
Funding summaryUpdated 26 Oct 2026
$158Mraised across 5 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by enobia.comSEC filing: $20M sold, first sale Aug 2011
No investor was named in the report.
Reported by sec.govSEC filing: $15M sold, first sale Mar 2011
Reported by enobia.comSEC filing: $15M sold, first sale Aug 2009
Reported by enobia.com
Reported by researchviews.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Desjardins Venture Capital
OrbiMed
Fonds de solidarite FtqLothian Partners
CTI CapitalT2C2 Capital
Innova-Tech ConsultingFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Enobia Pharma's investors include Desjardins Venture Capital, OrbiMed, Fonds de solidarite Ftq, Lothian Partners and CTI Capital, and 2 more on record.
Enobia Pharma has raised $158M across 5 rounds since 2005.
Enobia Pharma's most recent round was a Venture of $40M in Aug 2011.
Enobia Pharma's largest round on record is $50M (Series C), in Aug 2009.
Enobia Pharma's first round on record, in Jan 2005, was backed by Desjardins Venture Capital, Fonds de solidarite Ftq and T2C2 Capital and 1 others.
Enobia Pharma's latest named round is a Venture, in Aug 2011.
Enobia Pharma is based in Canada.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Canada · 
